Acceleron Pharma Inc.

United States of America

 
Total IP 366
Total IP Rank # 3,414
IP Activity Score 3.1/5.0    218
IP Activity Rank # 3,216
Stock Symbol XLRN (nasdaq)
ISIN US00434H1086
Market Cap. 6,900M  (USD)
Industry Biotechnology
Sector Healthcare

Patents

Trademarks

188 0
72 0
106 0
0
 
Last Patent 2023 - Alk7 binding proteins and uses t...
First Patent 2005 - Alk7 and myostatin inhibitors an...

Latest Inventions, Goods, Services

2023 Invention Alk7 binding proteins and uses thereof. This disclosure provides ALK7-binding proteins such as a...
Invention Treatments for complications associated with chronic liver disease. In certain aspects, the pres...
Invention Treatments for hermansky-pudlak syndrome. In certain aspects, the present disclosure relates to ...
Invention Twisted gastrulation polypeptides and uses thereof. In certain aspects, the present invention pr...
2022 Invention Activin-actrii antagonists and uses for treating anemia. Provided herein are methods for the tre...
Invention Tgf-beta superfamily type i and type ii receptor heteromultimers and uses thereof. In certain as...
Invention Compositions and methods for treating renal diseases or conditions. In some aspects, the disclosu...
Invention Actrii proteins and uses thereof. In some aspects, the disclosure relates to compositions and met...
Invention Compositions and methods for treating pulmonary hypertension. In some aspects, the disclosure rel...
Invention Actrii proteins and uses thereof. e.g.e.g.e.g., pulmonary hypertension associated with chronic ob...
Invention Actrii-alk4 antagonists and methods of treating heart failure. In some aspects, the disclosure re...
Invention Variant actriib proteins and uses thereof. In certain aspects, the present invention provides co...
Invention Alk4:actriib heteromultimers and uses thereof. In certain aspects, the disclosure provides solub...
Invention Variants derived from actriib and uses therefor. In certain aspects, the present invention provi...
2021 Invention Alk1 receptor and ligand antagonists and uses thereof. In certain aspects, the present disclosur...
Invention Methods for treating myeloproliferative disorders. In part, the present disclosure relates metho...
Invention Formulations comprising actrii polypeptide variants. In certain aspects, the present disclosure ...
Invention Formulations comprising actrii polypeptide variants. In certain aspects, the present disclosure p...
Invention Methods and compositions for treating ulcers. The present disclosure provides compositions and m...
Invention Alk7 antagonists and uses thereof. In certain aspects, the disclosure provides ALK7 antagonists....
Invention Method for promoting bone growth using activin-actriia antagonists. In certain aspects, the pres...
Invention Methods for increasing red blood cell levels and treating ineffective erythropoiesis. In certain...
Invention Activin-actrii antagonists and uses for increasing red blood cell levels. In certain aspects, th...
Invention Antagonists of activin-actriia and uses for increasing red blood cell levels. In certain aspects...
Invention Truncated actriib-fc fusion proteins. In certain aspects, the present invention provides composi...
Invention Actrii proteins for the treatment of pulmonary arterial hypertension (pah). In some aspects, the...
Invention Bmp-alk3 antagonists and uses for promoting bone growth. In certain aspects, the present inventi...
Invention Methods for dosing an actriib antagonist and monitoring of treated patients. In certain aspects,...
Invention Alk7:actriib heteromultimers and uses thereof. In certain aspects, the disclosure provides solubl...
Invention Actrii proteins and use in treating post-capillary pulmonary hypertension. In some aspects, the ...
Invention Single-arm actriia and actriib heteromultimers and methods for treating renal diseases or conditi...
Invention Variant actriib proteins and uses thereof. In certain aspects, the present invention provides no...
2020 Invention Single-arm actriia and actriib heteromultimers and methods for treating pulmonary hypertension. ...
Invention Compositions and methods for treating pulmonary hypertension. In some aspects, the disclosure re...
Invention Actrii-binding proteins and uses thereof. This disclosure provides ActRII-binding proteins such ...
2019 Invention Multispecific binders of tgfbeta-superfamily ligands and uses thereof. In certain aspects, the d...
Invention Methods for treating heterotopic ossification. In part, the present disclosure relates methods f...
2017 Invention Compositions and method for treating kidney disease. In some aspects, the disclosure relates to ...